In 2024, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) provided useful insights to the healthcare industry regarding how it approaches various fraud and abuse issues in an increasingly complex healthcare environment.
OIG identified several critical risk areas facing federal healthcare programs, issuing a Special Fraud Alert on Medicare Advantage Marketing and reports on using health risk assessments in Medicare Advantage (MA) and billing for Remote Patient Monitoring (RPM). OIG also settled with stakeholders who self-disclosed conduct for tens of millions of dollars, issued important advisory opinions and FAQs, published new compliance program guidance, all while continuing to defend the agency’s interpretation of the anti-kickback statute in defensive litigation related to advisory opinions.
Please see full publication below for more information.
